Synthetic peptides - a new approach for myocarditis and dilated cardiomyopathy Newsletter Article 17 February 2013 Pages: 1 - 1
Janssen's itraconazole is superior to nystatin in neutropenia Newsletter Article 17 February 2013 Pages: 1 - 1
A bacterial rather than a viral cause for rheumatoid arthritis is proposed Newsletter Article 17 February 2013 Pages: 2 - 2
The metabolic effects of propranolol may have a role in the prevention of ascites Newsletter Article 17 February 2013 Pages: 2 - 3
Developments in the treatment of children with HIV infections Newsletter Article 17 February 2013 Pages: 3 - 3
The risks and benefits of warfarin and aspirin in atrial fibrillation Newsletter Article 17 February 2013 Pages: 3 - 3
Questions remain regarding corticosteroid use in infectious keratitis Newsletter Article 17 February 2013 Pages: 4 - 4
Interleukin 2-activated bone marrow provides a new angle in CMV prevention … Newsletter Article 17 February 2013 Pages: 4 - 4
… and human monoclonal neutralising antibodies against CMV achieve high serum levels in BMT recipients Newsletter Article 17 February 2013 Pages: 4 - 5
Prevention of bone resorption by chlorthalidone in immobilised patients should be further investigated Newsletter Article 17 February 2013 Pages: 5 - 5
SD-3211 appears to reduce coronary vasospasm and to protect against ischaemic damage Newsletter Article 17 February 2013 Pages: 5 - 5
Johnson and Johnson's thymopentin may prevent surgery-induced immunosuppression Newsletter Article 17 February 2013 Pages: 5 - 5
Benefits of ‘Wellferon’ outlast those of interferon alpha N3 in recurrent respiratory papillomatosis Newsletter Article 17 February 2013 Pages: 6 - 6
… and enhances the anti-tumour effects of neutrophils Newsletter Article 17 February 2013 Pages: 7 - 7
R73 MAb prevents induction and reduces progression of collagen-induced arthritis in rats Newsletter Article 17 February 2013 Pages: 7 - 8
Dexamethasone-a novel approach in depressive disorders Newsletter Article 17 February 2013 Pages: 8 - 8
Low dose FSH fertility therapy is safe and cost-effective Newsletter Article 17 February 2013 Pages: 8 - 8
Combining alteplase and streptokinase in MI improves efficacy and reduces costs Newsletter Article 17 February 2013 Pages: 8 - 9
Organon's dexamethasone costs less than Glaxo's ondansetron Newsletter Article 17 February 2013 Pages: 9 - 9
Ondansetron - a second line agent except in highly emetic regimens Newsletter Article 17 February 2013 Pages: 9 - 9
Sulbactam + ampicillin is cost-effective for gonorrhoea in Malaysia Newsletter Article 17 February 2013 Pages: 9 - 10
Low dose zidovudine is safe and well tolerated in children with HIV infection Newsletter Article 17 February 2013 Pages: 10 - 10
Alteplase regimens receive more attention: high patency rates with bolus administration after MI Newsletter Article 17 February 2013 Pages: 10 - 10
Psyllium lowers cholesterol levels better than other selected bulk-forming laxatives Newsletter Article 17 February 2013 Pages: 10 - 11
Pyridoxine reduces vomiting and severe nausea in pregnancy Newsletter Article 17 February 2013 Pages: 11 - 11
Ondansetron + dexamethasone is superior to ondansetron alone in the control of cisplatin-induced emesis Newsletter Article 17 February 2013 Pages: 12 - 12
High dose pulsed dexamethasone should be considered before splenectomy in ITP Newsletter Article 17 February 2013 Pages: 12 - 12
SR adinazolam reduces symptom recurrence during dosage tapering in anxiety and panic disorders Newsletter Article 17 February 2013 Pages: 12 - 13
Topical diphencyprone induces hair regrowth in children with alopecia Newsletter Article 17 February 2013 Pages: 14 - 14
Anaesthesia with propofol can reduce vomiting and recovery time after surgery for strabismus in children Newsletter Article 17 February 2013 Pages: 14 - 14
Gemeprost preparation can also be used in second trimester dilatation and evacuation Newsletter Article 17 February 2013 Pages: 14 - 15
Lower FSH doses reduce complications in fertility therapy Newsletter Article 17 February 2013 Pages: 15 - 15
Fluoxetine and nortriptyline are equals in major depression therapy … Newsletter Article 17 February 2013 Pages: 15 - 15
… and depressed medically ill patients rapidly respond to methylphenidate Newsletter Article 17 February 2013 Pages: 15 - 16
Wellcome's aciclovir ends the era of corticosteroids in acute herpes zoster ophthalmicus Newsletter Article 17 February 2013 Pages: 16 - 16
Striving for the eradication of tuberculosis in the USA Newsletter Article 17 February 2013 Pages: 16 - 16
Acarbose should be considered as first-line therapy in NIDDM when diet alone is not enough Newsletter Article 17 February 2013 Pages: 16 - 17
Topical chlormethine controls skin involvement in childhood Langerhans cell histiocytosis Newsletter Article 17 February 2013 Pages: 17 - 17
Nabumetone has similar efficacy to indomethacin in ankylosing spondylitis Newsletter Article 17 February 2013 Pages: 17 - 17
Azacitidine has a place in the treatment of myelodysplastic syndromes Newsletter Article 17 February 2013 Pages: 18 - 18
Intrahepatic ‘Lipoidol’ + doxorubicin offers hope in hepatocellular carcinoma Newsletter Article 17 February 2013 Pages: 18 - 18
Sandoz's synthetic salmon calcitonin suppositories compare well with IM administration Newsletter Article 17 February 2013 Pages: 19 - 19
Inhaled budesonide has less effect on mineral metabolism than oral prednisolone Newsletter Article 17 February 2013 Pages: 19 - 19
Haemophilus influenzae type b polysaccharide vaccine is suitable as a booster in infants aged 7 to 15 months Newsletter Article 17 February 2013 Pages: 19 - 20